Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 1
Author(s): José Augusto Nogueira-Machado
Affiliation:
Export Options
About this article
Cite this article as:
Nogueira-Machado Augusto José, Meet Our Editorial Board Member, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2016; 10 (1) . https://dx.doi.org/10.2174/187221481001161005181428
DOI https://dx.doi.org/10.2174/187221481001161005181428 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
14
Related Articles
-
The Click Test: A Novel Tool to Quantify the Age-Related Decline of Fast Motor Sequencing of the Thumb
Current Aging Science Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited
Current Medicinal Chemistry Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration
Current Neurovascular Research Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Current Alzheimer Research Drug Repurposing in the Development of Anticancer Agents
Current Medicinal Chemistry Therapeutic Potential and Clinical Evidence of Hesperidin as Neuroprotective Agent
Central Nervous System Agents in Medicinal Chemistry Protein Aggregation and Self Assembly in Health and Disease
Current Proteomics Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
Current Medicinal Chemistry Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Current Neuropharmacology Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
CNS & Neurological Disorders - Drug Targets Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases
Current Drug Therapy Frontier View on Nanotechnological Strategies for Neuro-therapy
Current Drug Metabolism The Quest for Novel Biomarkers in Early Diagnosis of Diabetic Neuropathy
Current Proteomics Aggresome Formation and Neurodegenerative Diseases: Therapeutic Implications
Current Medicinal Chemistry Biomarkers of Cell Damage Induced by Oxidative Stress in Parkinsons Disease and Related Models
Central Nervous System Agents in Medicinal Chemistry Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Current Pharmaceutical Design Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals
Current Gene Therapy New Horizons in the Treatment of Neurological Disorders with Tailorable Gold Nanoparticles
Current Drug Metabolism Humanin; A Defender Against Alzheimers Disease?
Recent Patents on CNS Drug Discovery (Discontinued)